Increased release of polymorphonuclear leucocyte (PMNL) elastase, when the PMNLs are activated, can damage tissues in vivo. It was postulated that PMNL elastase might have a tissue-remodelling effect in the body and that obese individuals might have less PMNL elastase activity than lean individuals. To test this hypothesis, plasma PMNL elastase levels were determined in 70 obese individuals and 30 lean normal controls. The PMNL elastase levels (determined by enzyme-linked immunosorbent assay) in the obese group (median 36.2 ng/ml) did not differ significantly from those in the lean healthy controls (32.6 ng/ml; P = 0.5).
DowseGKZimmetPZGareebooHAbdominal obesity and physical inactivity as risk factors for NIDDM and impaired glucose tolerance in Indian, Creole, and Chinese Mauritians. Diabetes Care1991; 14: 271–282.
2.
LarssonHAhrenBIslet cell dysfunction in obese women with impaired glucose tolerance. Metabolism1996; 45: 502–509.
3.
OhlsenL-OLarssonBSvardsuddKThe influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes1985; 34: 1055–1058.
4.
OlefskyMKoltermanOGScarletJAInsulin action and resistance in obesity and non-insulin dependent type II diabetes mellitus. Am J Physiol1982; 243: E15–E30.
5.
VagueJThe degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. AmJ Nutr1956; 4: 20–34.
6.
PlaistedCSIstfanNWMetabolic abnormalities of obesity. In: Obesity: Pathophysiology, Psychology and Treatment (Blackburn GL, Kanders BS, eds). New York: Chapman and Hall, 1994; pp 80–97.
7.
TanakaSInoueSIsodaFImpaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes1993; 17 (11): 631–636.
8.
DattiloAMKris-EthertonPMThe effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr1992; 52: 320–328.
9.
StalloneDDThe influence of obesity and its treatment on the immune system. NutrRev1994; 52: 37–50.
10.
AdeyemiEOChadwickVSHodgsonHJFThe effect of some anti-inflammatory agents on elastase release from neutrophils in-vitro. J Pharm Pharmacol1990; 42: 487–490.
TreuhaftPSMcCartyDJSynovial pH, lactate, oxygen and carbon dioxide partial pressure in various joint diseases. Arthritis Rheum1971; 14: 475–484.
14.
VelvartMFehrICBaiciADegradation in vivo of articular cartilage in rheumatoid arthritis by leucocyte elastase from polymorphonuclear leucocytes. Rheumatol Int1981; 1: 121–130.
15.
Declaration of Helsinki: Recommendations guiding medical doctors on biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, 1964, and revised by the 29th World Medical Assembly, Tokyo, Japan, 1975.
16.
WHO Expert Committee on Physical Status: The use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva: World Health Organization, 1995; WHO Tech Report Series no. 854.
17.
BironCAActivation and function of natural killer cell responses during viral infections. Curr Opin Immunol1977; 9: 24–34.
18.
TrichieriGCytokines acting on or secreted by macrophages during intracellular infection (IL10, IL12, IFN-γ). Curr Opin Immunol1997; 9: 17–23.
19.
BouttenAMSDehouxNSetaJCompartmentalized IL-8 and elastase release within the human lung in unilateral pneumonia. Am J Respir Crit Care Med1996; 153: 336–342.
